Evidence map›Paper›PMID 35468146›Full record

ArticlePLoS neglected tropical diseases2022

Identification of asymptomatic Entamoeba histolytica infection by a serological screening test: A cross-sectional study of an HIV-negative men who have sex with men cohort in Japan.

Yasuaki Yanagawa, Rieko Shimogawara, Misao Takano, Takahiro Aoki, Daisuke Mizushima, Hiroyuki Gatanaga, Yoshimi Kikuchi, Shinichi Oka, Kenji Yagita, Koji Watanabe

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Diversity and Plasticity of Virulent Characteristics ofTropical medicine and infectious disease · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Yasuaki YanagawaAIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, Japan.
Rieko ShimogawaraDepartment of Parasitology, National Institutes of Infectious Diseases, Tokyo, Japan.
Misao TakanoAIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, Japan.ORCID 0000-0001-5059-110X
Takahiro AokiAIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, Japan.
Daisuke MizushimaAIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, Japan.
Hiroyuki GatanagaAIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, Japan.
Yoshimi KikuchiAIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, Japan.
Shinichi OkaAIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, Japan.ORCID 0000-0002-9283-2167
Kenji YagitaDepartment of Parasitology, National Institutes of Infectious Diseases, Tokyo, Japan.
Koji WatanabeAIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, Japan.ORCID 0000-0002-3190-8439
National Center for Global Health and Medicine · JPNational Institute of Infectious Diseases · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAmebiasis, caused by Entamoeba histolytica, is spreading in developing countries and in many developed countries as a sexually transmitted infection. Here, we evaluated the efficacy of serological screening to identify asymptomatic E. histolytica infection as a potential epidemiological control measure to limit its spread. METHODOLOGY/PRINCIPAL

findingsThis cross-sectional study was carried out between January and March 2021 in an HIV-negative men who have sex with men (MSM) cohort at the National Center for Global Health and Medicine. Serological screening was performed using a commercially available ELISA kit. For seropositive individuals, we performed stool polymerase chain reaction (PCR) to determine current E. histolytica infection. We performed E. histolytica serological screening of 312 participants. None had a history of E. histolytica infection prior to the study. The overall E. histolytica seropositivity was 6.7% (21/312), which was similar to that found by the rapid plasma reagin test (17/312). We identified current infection in 8 of 20 seropositive participants (40.0%) by stool PCR. CONCLUSIONS/SIGNIFICANCE: Our serological screening approach constitutes a potentially practical epidemiological strategy. Active epidemiological surveys, in combination with an effective screening strategy for asymptomatically infected individuals, should be applied to help reduce sexually transmitted E. histolytica infections.

Indexed as

Entamoeba histolyticaEntamoebiasisHIV InfectionsSexual and Gender MinoritiesSexually Transmitted DiseasesCross-Sectional StudiesFecesHomosexuality, MaleHumansJapanMale

Identifiers

PMID35468146
PMCPMC9071119
OpenAlexW4224865621

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.